$48.87
-3.55-6.77%
Last update: Nov 5, 4:00 PM
Travere Therapeutics Inc
TVTXNASDAQ
The average analyst price target for Travere Therapeutics is $51.22, 4.8% above the current price. Of 15 analysts, 13 rate it Buy and 2 Hold. Targets range from $11 to $85. The latest change came on Nov 5, 2026, when Leerink Partners lowered its price target on Travere Therapeutics from $78 to $67 and kept an Outperform rating.
Price Target Range — 12 Quarters
Analyst Consensus — 15 Analysts
Rating Trend — Last 9 Months
